Clinical trial
Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma
NCT00187122 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00187122 |
|---|---|
| Title | Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma |
| Official title | Treatment for Newly Diagnosed Patients With Stage III/IV Non-Hodgkin Lymphoma-Study XIII (A Therapeutic Pilot Study) |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Lymphoblastic Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | Vincristine, Radiation Therapy, Daunomycin, L-Asparaginase, Cytarabine, Methotrexate, Mercaptopurine, Etoposide, Cyclophosphamide, Prednisone and 1 more |
| Enrollment | 42 |
| Start date | Mar 1, 1993 |
| Primary completion | Jun 1, 2004 |
| Completion | Jun 1, 2004 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 23, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: